Dalhousie’s Soillse Prostate Cancer Quality of Life Research Lab is led by Dr. Gabriela Ilie and examines how patient characteristics and psychosocial factors affect the relationship between disease specific and general health quality of life outcomes and various forms of contemporary prostate cancer treatments.
Dr. Ilie’s substantive interests are in the areas of prostate cancer functional and psychosocial quality of life outcomes, patient-partner dyadic congruence, population health, mental health, substance use, concussions and traumatic brain injury, injury prevention, and health policy. She is particularly interested in the intersection of chronic illness and various patient-reported disease specific and psychosocial quality of life outcomes, among adolescents, adults and older adults.
Dr. Ilie’s laboratory is currently conducting a Maritimes prostate cancer patient-reported outcomes project that examines how prostate cancer quality of life outcomes are affected by treatment type, cancer related factors, patient, and patient-partner dyadic characteristics. Lab members are working in close collaboration with clinicians from NS, NB and PEI, researchers from BC, Alberta, Ontario, and US, to advance our understanding of positive quality of life outcomes following a prostate cancer diagnosis and treatment. Dr. Ilie collaborates nationally and internationally with researchers in the area of concussion and traumatic brain injury looking at understanding risks and consequences of brain injury and how psychosocial determinants of health influence quality of life outcomes among injured adolescents and adults.
Dr. Gabriela Ilie is currently supervising a number of graduate students and undergraduate research projects. The lab is also currently recruiting volunteers who are given an opportunity to gain insight into the research process and work alongside current lab members and clinicians.